Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humacyte (HUMA) Current Leases (2024 - 2025)

Humacyte has reported Current Leases over the past 2 years, most recently at $2.4 million for Q4 2025.

  • Quarterly results put Current Leases at $2.4 million for Q4 2025, down 16.76% from a year ago — trailing twelve months through Dec 2025 was $2.4 million (down 16.76% YoY), and the annual figure for FY2025 was $2.4 million, down 16.76%.
  • Current Leases for Q4 2025 was $2.4 million at Humacyte, down from $2.7 million in the prior quarter.
  • Over the last five years, Current Leases for HUMA hit a ceiling of $3.1 million in Q2 2025 and a floor of $2.4 million in Q4 2025.